StockData
Electra Therapeutics, Inc. logo

Electra Therapeutics, Inc. (ETRA) stock

ETRANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026
$8.43+0.08 (+0.96%)

Close on Nov 18, 2026Market cap $529.97MP/E –Yield –

Electra Therapeutics operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026-$25.06M–
Q3 FY2025Sep 30, 2025-$17.02M–

More Electra Therapeutics figures

See a number that looks wrong?